Testing the Safety and Efficacy of the Addition of a New Anti-cancer Drug, ZEN003694, to Chemotherapy Treatment (Cisplatin and Etoposide or Carboplatin and Paclitaxel) for Adult and Pediatric Patients (12-17 Years) With NUT Carcinoma
Clinical trial NCT05019716 · RECRUITING
Trial details
- NCT number
- NCT05019716
- Sponsor
- National Cancer Institute (NCI)
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-07-13
- Primary completion
- 2027-06-07
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.